Kirsten ras mutations in patients with colorectal cancer:The multicenter “ RASCAL ” study [ J ] . J Natl Cancer Inst,1998,90.Randomized phase Ⅲ study of panitumumab with fluorouracil,leucovorin,and irinotecan(FOLFIRI)compared with FOLFIRI alone as second- ......